Title : Cardiovascular safety of the dipetidyl peptidase-4 inhibitor alogliptin in type 2 diabetes mellitus.

Pub. Date : 2013 Jul

PMID : 23489301






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AIM: As there have been concerns that some classes or agents for the treatment of type 2 diabetes may increase CV risk, we evaluated the cardiovascular profile of the dipeptidyl peptidase-4 inhibitor alogliptin. alogliptin dipeptidyl peptidase 4 Homo sapiens